Study on active compounds from Huoxiang Zhengqi Oral Liquid for prevention of coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking
Yan Jun Deng, Bowen Liu, Zhen Xiang He, Tao Liu, Rong Zheng, An Di Yang, Ao Huang, Yuting Li, Yu Xu
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PharmacologyCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineInfectious disease (medical specialty)VirologyChemistryDiseaseInternal medicineOutbreakPharmacological Effects of Natural CompoundsPlant-based Medicinal ResearchPhytochemistry and Biological Activities